• Company
• Acetaminophen prescriptions at a record high
• by Chon, Seung-Hyun Jul 26, 2023 05:41am

• Company
• MSD Korea appoints Albert Kim as new managing director
• by Eo, Yun-Ho Jul 26, 2023 05:41am

• Policy
• All Sandoz products removed from Korea’s reimb list
• by Lee, Tak-Sun Jul 26, 2023 05:41am

• Company
• Two types of JAK inhibitors start a full-scale competition
• by Eo, Yun-Ho Jul 26, 2023 05:40am

• Policy
• Yuhan’s low-dose atorvastatin combo receives reimb
• by Lee, Tak-Sun Jul 25, 2023 05:46am

• Company
• Decreased drug price and inclusion of impurities in Januvia
• by Jung, Sae-Im Jul 25, 2023 05:46am

• Policy
• Be aware of interstitial renal tubulitis when taking Vimovo
• by Lee, Hye-Kyung Jul 25, 2023 05:45am

• Company
• 'Paxlovid reduces the risk of deaths in high-risk groups'
• by Jung, Sae-Im Jul 25, 2023 05:45am

• Company
• Cinqair’s quicker reimb renders reimb difficult for others
• by Eo, Yun-Ho Jul 25, 2023 05:45am

• Company
• Original Forxiga’s sales strong despite generic entry
• by Kim, Jin-Gu Jul 24, 2023 05:26am